$17.30
-0.30-1.70%
At close: -
$17.60
0.301.73%
After Hours: 7:12 AM EDT
Comments
Loading...
Telix Pharmaceuticals Stock Guidance | NASDAQ:TLX | Benzinga
Telix Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/20/2025 | TLX | Telix Pharmaceuticals | FY | 2025 | — | — | — | $770.00M | $800.00M | $747.07M | Get Alert |
FAQ
What is the most recent guidance for Telix Pharmaceuticals (TLX)?
There have been no specific sales or earnings guidance reported for Telix Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.